Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-4155000 in Net Income for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Net Income including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-3704000 in EBIT for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Ebit including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $61.22M in Assets for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Assets including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-0.36 in Interest Income for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Interest Income including historical, tables and charts were last updated by Trading Economics this last April in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported 10.14M in Outstanding Shares in January of 2025. Data for Acasti Pharma | ACST - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-0.36 in Trade Creditors for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-0.36 in Selling and Administration Expenses for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Selling And Administration Expenses including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $0 in Interest Expense on Debt for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $52.14M in Equity Capital and Reserves for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Equity Capital And Reserves including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AMD's data center business struggles cast a shadow on its stock performance, highlighting challenges in AI computing and competition with Nvidia.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $11.06M in Cash and Equivalent for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Cash And Equivalent including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.